SRS versus WBRT for resected brain metastases Reply

被引：0
|
作者：
Roberge, David [1 ]
Brown, Paul [2 ]
机构：
[1] Ctr Hosp Univ Montreal, Dept Radiat Oncol, Montreal, PQ, Canada
[2] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 10期
关键词：
POSTOPERATIVE STEREOTACTIC RADIOSURGERY; PHASE-3; TRIAL; RADIOTHERAPY;
D O I：
10.1016/S1470-2045(17)30703-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E560 / E560
页数：1
相关论文
共 50 条
  • [41] Reply to: "Assessment of imaging biomarkers in the follow-up of brain metastases after SRS"
    Cicone, Francesco
    Cascini, Giuseppe Lucio
    Minniti, Giuseppe
    NEURO-ONCOLOGY, 2021, 23 (11) : 1985 - 1986
  • [42] Neurocognitive function after WBRT plus SRS or SRS alone
    Weiss, Stephanie E.
    Kelly, Paul J.
    LANCET ONCOLOGY, 2010, 11 (03): : 220 - 221
  • [43] AI-BASED ASSESSMENT OF BRAIN VOLUME DECREASE AFTER SRS AND WBRT
    Thiele, Frederic
    Kawula, Maria
    Katzendobler, Sophie
    Bodensohn, Raphael
    Kurz, Christopher
    Landry, Guillaum
    Weller, Jonathan
    Niyazi, Maximilian
    NEURO-ONCOLOGY, 2023, 25
  • [44] RTOG 0320:A phase Ill trial comparing whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT with temozolomide (TMZ) or erlotinib for non-small cell lung cancer (NSCLC) and 1-3 brain metastases
    Sperduto, Paul W.
    Wang, Meihua
    Robins, H. Ian
    Schell, Michael C.
    Werner-Wasik, Maria
    Komaki, Ritsuko U.
    Souhami, Luis
    Buyyounouski, Mark K.
    Khuntia, Deepak
    Demas, William F.
    Shah, Sunjay A.
    Nedzi, Lucien A.
    Perry, G. A.
    Suh, John H.
    Mehta, Minesh P.
    CANCER RESEARCH, 2012, 72
  • [45] A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT & SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320 Reply
    Sperduto, Paul W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (05): : 810 - 810
  • [46] Phase 3 Trial of Whole Brain Radiotherapy with Concurrent Erlotinib Versus WBRT Alone for NSCLC with Brain Metastases (ENTER)
    Yang, Z.
    Zhang, Y.
    Li, R.
    Yisikandaer, A.
    Ren, B.
    Sun, J.
    Li, J.
    Chen, L.
    Zhao, R.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S381 - S382
  • [47] SURGICAL RESECTION(S) PLUS STEREOTACTIC RADIOSURGERY (SRS) VERSUS SRS ALONE FOR LARGE BRAIN METASTASES: A COMPARATIVE STUDY
    Millar, Barbara-Ann
    Laperriere, Normand
    Conrad, Tatiana
    Kalyvas, Aristotelis
    Zadeh, Gelareh
    Bernstein, Mark
    Kongkham, Paul
    Weiss, Jessica
    Shultz, David
    Gutierrez, Enrique
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S68 - S68
  • [48] WBRT plus SRS for Tumors in Eloquent Locations: But Why Give the WBRT?
    Sahgal, Arjun
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2015, 42 (05) : 283 - 283
  • [49] Clinical Outcomes of Patients Treated With Repeated Courses of Stereotactic Radiosurgery (SRS) Without Prior Whole-Brain Radiation Therapy (WBRT) for Recurrent Brain Metastases
    Silva, D. A.
    Coelho, T. M.
    AmbrAsio, A. V. A.
    Leao, C. R.
    Pellizzon, C.
    Fogaroli, R. C.
    Silva, M. L. G.
    Chen, M. J.
    Gondim, G.
    Castro, D. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E104 - E104
  • [50] Comparing pre-operative stereotactic radiosurgery (SRS) to postoperative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis
    Patel, Kirtesh R.
    Burri, Stuart H.
    Boselli, Danielle
    Symanowski, James T.
    Asher, Anthony L.
    Sumrall, Ashley
    Fraser, Robert W.
    Press, Robert H.
    Zhong, Jim
    Cassidy, Richard J.
    Olson, Jeffrey J.
    Curran, Walter J.
    Shu, Hui-Kuo G.
    Crocker, Ian R.
    Prabhu, Roshan S.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (03) : 611 - 618
12345